Field decision-tree logic for expedition medics separating localized frostbite from systemic AMS/HAPE/HACE when both share the same cold + hypoxic exposure
Cold and altitude are not separate hazards on a high mountain — they are the same exposure. A climber above 5,000 m in sub-zero wind experiences peripheral vasoconstriction (setting up frostbite) and hypobaric hypoxia (setting up AMS/HAPE/HACE) simultaneously, so a single patient reporting numb fingers and a splitting headache is not presenting with two coincidental problems — they are two expected outputs of the same physiologic stress.
A shivering, fatigued climber with cold hands is easy to write off as "just cold" — but peripheral vasoconstriction that protects the core also starves the fingers and toes of blood flow, and that same vasoconstriction plus reduced oxygen delivery is exactly what produces the throbbing frontal headache of Acute Mountain Sickness (AMS). Fatigue, poor judgment, and clumsy movement can be argued as symptoms of either cold stress or early cerebral hypoxia, which is precisely why field triage cannot rely on a single symptom cluster — it has to branch the exam into two independent tracks.
Expedition case series consistently show that members presenting with digit pain or numbness at altitudes above 6,000 m frequently also screen positive for at least mild AMS on a Lake Louise Score, simply because everyone at that altitude is hypoxic to some degree — the presence of frostbite does not rule out concurrent altitude illness, and vice versa.
Wilderness Medical Society (WMS) practice guidelines for both frostbite and high-altitude illness are structured as staged algorithms rather than single checklists: first stabilize and stop ongoing injury (get out of the wind, stop further ascent), then classify severity with a defined exam, then apply management rules gated by that classification. Running two such algorithms in parallel — one for the extremities, one for the neuro/pulmonary system — mirrors exactly how a two-branch decision tree should be built for a combined presentation.
The single most important field principle: never let the more visually dramatic or painful complaint (frostbitten fingers) distract from screening the systemic exam — a subtle early HACE presentation can look calmer than a climber wincing over blistered fingers, yet be the one that kills within hours if descent is delayed.
Before branching into the two detailed exams, a rapid primary sweep establishes the baseline: current altitude and rate of ascent over the last 24–48 hours (the single strongest predictor of altitude illness risk), duration and severity of cold/wind exposure, hydration and caloric intake, and any pre-existing conditions or medications (acetazolamide prophylaxis, for instance, changes the pretest probability of AMS). Gloves and boots are removed for a visual and tactile check of every digit even if the climber only complains about one hand, since cold injury frequently affects multiple extremities asymmetrically and a climber preoccupied with pain in one hand may not have noticed numbness developing in their toes.
This primary sweep takes under two minutes but sets up both branch exams that follow — it is the equivalent of a "scene size-up" in any structured field triage protocol, and skipping it is the most common source of an incomplete or rushed downstream assessment.
The extremity exam is a localized, tissue-level assessment — color, texture, sensation, and capillary refill sort a cold digit into one of three severity tiers, each with a different (but non-emergent) management path. Unlike the altitude branch, a positive frostbite finding by itself is not an indication for emergency descent.
Frostnip presents as pale, cold, numb skin that regains sensation and color quickly with rewarming and leaves no lasting damage — it is a warning sign, not an injury. Superficial frostbite has progressed to actual tissue freezing in skin and the fat layer beneath it: the digit feels hard or waxy at the surface but still yields slightly to pressure underneath, and clear or milky fluid-filled blisters typically form within a day or two of rewarming. Deep frostbite means the freeze has reached muscle, tendon, or bone — the tissue is hard all the way through like frozen meat, sensation is completely absent, and blisters (when they appear) are hemorrhagic (blood-filled), a strong predictor that the tissue underneath will not survive.
Capillary refill is one of the fastest field discriminators: a digit that refills pink within 2–3 seconds after gentle compression has intact perfusion; one that stays white or grey with no refill signals a much deeper injury requiring more aggressive definitive care once evacuation is possible.
A frostbitten hand is a serious, potentially disfiguring injury — but it is very rarely acutely life-threatening over the timescale of a multi-day evacuation. This is the critical branching insight the decision tree encodes: extremity findings alone should not override an otherwise stable systemic/neuro exam when deciding whether the whole team needs to descend right now. What frostbite does demand is stopping the ongoing cold exposure (dry insulation, wind protection, avoiding tight boots/gloves that further restrict circulation) and, crucially, a careful decision about whether to actively rewarm in the field — covered in Stage 4.
The severity grade assigned in the field exam correlates strongly with eventual tissue outcome: frostnip essentially never results in tissue loss, superficial frostbite carries a modest risk usually limited to skin, and deep frostbite carries a substantial risk of partial or full digit amputation, particularly when rewarming is delayed beyond 24 hours or a freeze-thaw-refreeze cycle occurs. Because the field grade cannot be fully finalized until after rewarming (a digit that looks superficial when still frozen can turn out deeper once thawed and demarcation lines appear over the following days to weeks), the initial exam is best treated as a working triage estimate rather than a final prognosis.
This is also why frostbite management in modern hospital settings has shifted toward earlier use of thrombolytic and vasodilator therapies in deep cases — treatments only available once the patient reaches definitive care, reinforcing that the field team's job is safe transport and tissue protection, not attempting to resolve tissue viability on the mountain.
The systemic/neuro exam screens for a spectrum of altitude illness that ranges from a self-limiting headache syndrome to two genuinely emergent conditions. Unlike frostbite, findings on this branch — particularly ataxia or pulmonary crackles with breathlessness at rest — can mandate immediate descent regardless of any other injury present.
AMS is diagnosed clinically: a headache after a recent gain in sleeping altitude plus at least one of nausea/vomiting, fatigue, dizziness, or difficulty sleeping — no imaging or lab test is available or needed in the field. The tandem gait test (walking heel-to-toe along a straight line) is the single most useful discriminator for High Altitude Cerebral Edema (HACE): a climber who cannot walk a straight line, combined with any alteration in mental status (confusion, drowsiness, irrational behavior), is treated as HACE until proven otherwise. Lung auscultation listening for crackles, combined with breathlessness that persists at rest (not just on exertion), screens for High Altitude Pulmonary Edema (HAPE) — often accompanied by a dry cough progressing to pink, frothy sputum in advanced cases.
These three conditions form a severity spectrum but are not strictly sequential — HAPE and HACE can each occur without severe preceding AMS, and either can develop with frightening speed, sometimes within a matter of hours of the first mild symptoms.
The table below is the practical version of the systemic decision branch — what a medic is actually screening for, how urgent each finding is, and whether descent is mandatory.
A failed tandem gait test in a climber above 3,500 m should be treated as HACE and trigger immediate descent even if the climber insists they "just feel a little off" — mental status changes in the patient themselves are notoriously unreliable self-reports, since impaired judgment is part of the disease.
A pulse oximeter, if carried, adds useful supporting data — an SpO2 markedly lower than what is typical for the group at that altitude is suggestive of HAPE, though altitude, acclimatization state, and exertion all shift the "normal" baseline enough that oximetry should never override the clinical exam findings on gait and mental status. Medications carried by well-prepared expeditions (acetazolamide for AMS treatment/prevention, dexamethasone for HACE, nifedipine for HAPE) are field-management tools, not diagnostic ones — they buy time and reduce severity during descent, but drug response should never be used to justify delaying descent for a patient who meets HACE or HAPE criteria.
The Lake Louise Score, a simple self-report and observer questionnaire covering headache, GI symptoms, fatigue, dizziness, and sleep quality, remains the most widely taught field scoring tool for AMS specifically because it requires no equipment and can be administered by any team member in under a minute.
Combined presentations are the norm, not the exception, at extreme altitude in cold conditions — which is exactly why the decision tree needs an explicit priority rule rather than leaving medics to weigh two urgent-feeling problems against each other under stress and fatigue.
The core clinical logic is a comparison of failure modes. Frostbite, even when severe, damages tissue on a timescale of days — the difference between a same-day and a three-day evacuation rarely changes whether a digit is salvageable, because the freezing injury itself already determined much of that outcome at the moment it occurred. HACE and HAPE, by contrast, are actively progressive processes where cerebral or pulmonary edema can worsen by the hour; a climber who is ambulatory and mildly confused at noon can be unresponsive by evening. This asymmetry in ticking-clock severity is why every major wilderness medicine protocol places unambiguous, unconditional priority on descent for altitude illness over any non-descent-requiring injury present at the same time.
This does not mean frostbite is ignored — it means frostbite management is folded into the descent that is already happening for altitude reasons, rather than being allowed to delay that descent.
A widely underappreciated rule in frostbite management is that active field rewarming should not be started if there is a realistic chance the tissue will refreeze before reaching definitive care. Warm water immersion (37–39°C) thaws frozen tissue, but if the evacuation route then re-exposes that now-perfused, now-fragile tissue to freezing temperatures again, the resulting freeze-thaw-refreeze cycle causes dramatically worse tissue damage and higher amputation rates than simply keeping the extremity frozen and insulated until a stable rewarming environment (a heated shelter, a lower-altitude camp) is guaranteed.
This is precisely why the priority rule and the refreeze caveat reinforce each other: because descent is already mandatory for altitude illness, it often also resolves the frostbite dilemma by moving the patient toward the lower, warmer, more stable environment where rewarming can finally be done safely and definitively — descent serves both problems even though it is triggered by only one of them.
Do not rewarm in the field if repeat freezing is plausible during onward evacuation — a frozen extremity that stays frozen until definitive care is a better outcome than one that is thawed, then refrozen on the trail down.
Rather than treating frostbite and altitude illness as two separate cases to manage independently, the decision tree resolves them into one triage output by comparing severity tiers across branches: any HAPE/HACE-tier finding on the systemic branch takes unconditional priority regardless of the extremity grade; below that threshold, the higher of the two branch severities determines the leading pathway, and genuinely comparable moderate severity on both branches is labeled a combined presentation requiring parallel management rather than sequential triage.
This combining logic mirrors how many wilderness protocols use tiered severity scoring (mild/moderate/severe) for each syndrome independently and then apply an explicit override rule for whichever finding carries the shortest time-to-harm — a structure deliberately designed to prevent a medic under stress from having to construct that comparison from first principles in the field.
The final stage converts the triage decision into a concrete, sequenced field action plan that a small expedition team can execute under stress — descent logistics, tissue protection, pain control, and remote medical consultation running in parallel rather than as an ad hoc scramble.
Once the dominant priority is established, the plan sequences as: (1) begin descent immediately if any HACE/HAPE criteria are met — even a modest drop in altitude (300–1,000 m) can produce rapid symptomatic improvement in HACE and HAPE; supplemental oxygen or a portable hyperbaric (Gamow) bag can bridge the gap if descent is temporarily impossible due to terrain or weather. (2) In parallel, frostbitten extremities are padded with bulky dry dressings, digits separated to avoid maceration, and kept from further mechanical trauma (no walking on refrozen/thawed feet if avoidable) — active rewarming is deferred until the team reaches a location where refreezing is no longer a realistic risk. (3) Pain control (typically NSAIDs such as ibuprofen, which is used both for AMS headache and for its theoretical benefit reducing frostbite-related tissue inflammation) is started early. (4) Findings are relayed to remote medical support via satellite phone or radio wherever possible — an experienced wilderness/altitude physician on the other end can help confirm the triage read and advise on evacuation urgency.
Route and method selection (walking descent vs. helicopter evacuation, if available and weather permits) is chosen to serve the dominant threat: a HACE patient who cannot safely self-ambulate needs assisted or mechanical evacuation, not a multi-day walk-out that further delays the only effective treatment.
Published expedition medicine case series from high-altitude peaks (e.g. Denali, the Himalaya) repeatedly describe the same combined pattern: members with frostbitten fingers or toes who are also found, on systematic exam, to have unrecognized moderate-to-severe AMS or early HACE signs that had been masked by attention to the more visibly dramatic cold injury. The recurring lesson in after-action reviews is procedural, not diagnostic — teams that ran a structured two-branch exam on every symptomatic member (rather than triaging by whichever complaint the climber mentioned first) caught the systemic illness earlier and avoided delayed descents.
The most consistent failure mode in real incidents is not misdiagnosing either syndrome individually — it is anchoring on the first, most visible complaint (frostbitten fingers) and never running the second exam branch at all.
Route and method selection weighs the dominant threat against terrain, weather, and available resources. Assisted walking descent is often the only realistic option on technical terrain or in weather that grounds aircraft, and it remains appropriate for a stable, ambulatory patient even with significant frostbite. A patient with altered mental status, ataxia, or respiratory distress at rest needs the fastest and least physically demanding evacuation method available — mechanical descent (helicopter, if flyable; a sled or litter carry otherwise) — because self-ambulation both delays arrival at definitive care and risks a fall or further deterioration en route.
Whichever method is chosen, the plan should build in scheduled reassessment checkpoints during the descent itself: altitude illness that is improving with descent confirms the diagnosis and plan; a patient who is not improving, or is worsening, after a meaningful altitude drop needs the evacuation escalated rather than assumed to be "in progress and fine."
A rule of thumb used in several wilderness medicine curricula: descend a patient with HACE or HAPE signs until they show clear improvement, not merely until they reach a pre-planned camp — the destination is defined by the patient's response, not the map.